// App-Quantinova.ai

: Improving clinical trial experience for patients and investigators through a simulated trial in palmoplantar pustulosis (PPP)

Researchers

Presenter

  • David Trigos

Principal Investigators

  • Andreas Pinter

  • Christian Boisvert-Huneault

  • Satomi Kobayashi

  • Stacie Bell

  • Tristan Gloede

  • Nobutaka Yagi

  • Steven Brunette

  • Yakov Datsenko

  • Frank Baehner

  • Peter van de Kerkhof

Medical Centers

  • EUROPSO, European Umbrella Federation for Psoriasis Associations, Polzela, Slovenia

  • Department of Dermatology, Venereology, and Allergology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany

  • Canadian Association of Psoriasis Patients, Ottawa, ON, Canada

  • Department of Dermatology, Seibo International Catholic Hospital, Tokyo, Japan

  • National Psoriasis Foundation, Portland, OR

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT

  • Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan

  • Boehringer Ingelheim International GmbH, Biberach, Germany

  • Department of Dermatology, Radboud University, Nijmegen, the Netherlands

Locations

  • United States

  • Slovenia

  • Netherlands

  • Germany

  • United Kingdom

  • Switzerland

  • Japan

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Dermatology

Disease

  • Psoriasis 14, pustular

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Placebo Control

  • Open Label

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved